  A potential impact of tricyclic antidepressants on oral anticoagulation is controversial. Phenprocoumon - the most commonly used anticoagulant in Germany - is rarely considered in clinical trials. In the present study, a potential drug-drug interaction between phenprocoumon and tricyclics, causing an alteration in prothrombinemic effects, has been investigated.  
